InvivoSciences
Business Services · Wisconsin, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
510 Charmany Dr Ste 60, Madison, Wiscons...Phone Number
(608) 628-8035Website
www.invivosciences.comRevenue
<$5 MillionIndustry
About InvivoSciences
InvivoSciences, Inc. is a precision medicine company focused on personalizing drug development through innovative 3D human micro-tissue technologies. Their platform utilizes patient-derived and gene-edited samples to enhance the safety and efficacy profiling of treatments, significantly reducing costs before clinical trials. Targeting pharmaceutical developers, InvivoSciences aims to mitigate clinical trial failures and develop patient-specific heart failure therapies. The company also engages in drug discovery for rare and genetically defined heart conditions, leveraging advanced automation and AI in their processes.Explore more
InvivoSciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to InvivoSciences
Compare insights from companies similar to InvivoSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
InvivoSciences Tech Stack
A closer look at the technologies used by InvivoSciences
See more technologies
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding InvivoSciences
Sign Up For FreeTo access detailed company insights
InvivoSciences, Inc. is a precision medicine company focused on personalizing drug development through innovative 3D human micro-tissue technologies. Their platform utilizes patient-derived and gene-edited samples to enhance the safety and efficacy profiling of treatments, significantly reducing costs before clinical trials. Targeting pharmaceutica... Read More
